Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

David M. Kurtz, MD PhD, Joanne Soo, MD, Stefan Alig, MD, Lyron Co Ting Keh, Charles Macaulay, Michael C. Jin, BS, Florian Scherer, MD, Emily G. Hamilton, BS, Chih Long Liu, PhD, Binbin Chen, PhD, Alexander F. M. Craig, MPhil, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 552.

https://doi.org/10.1182/blood-2019-131267

Published: 2019

Journal Articles

Class II HLA Epitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

Scott R Solomon, MD, Michael T Aubrey, CHS, Cheri Anobile, Xu Zhang, PhD, Brian M Freed, PhD DABHI, Lawrence E Morris, MD, H. Kent Holland, MD, Melhem Solh, MD, Asad Bashey, MD PhD

Blood (2018) 132 (Supplement 1): 311.

https://doi.org/10.1182/blood-2018-99-114122

Published: 2018

Journal Articles

Post-Transplantation High Dose Cyclophosphamide As Gvhd Prophylaxis in 9/10 HLA-Matched Unrelated Donors Hematopoietic Stem Cell Transplantation

Rohtesh S. Mehta, MD MPH, MS, Rima M Saliba, PhD, Julianne Chen, Gabriela Rondon, MD, Aimee E Hammerstrom, PharmD, BCOP, Amin M. Alousi, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Sairah Ahmed, MD, Uday R. Popat, MD, Chitra M. Hosing, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Stefan O. Ciurea, MD

Blood (2015) 126 (23): 3135.

https://doi.org/10.1182/blood.V126.23.3135.3135

Published: 2015

Journal Articles

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Shigeo Fuji, Julia Fischer, Markus Kapp, Thomas G Bumm, MD, Hermann Einsele, Stefan Stevanovic, PhD, Hans-Georg Rammensee, Prof., Thomas Hunig, Götz Ulrich Grigoleit, MD

Blood (2012) 120 (21): 4351.

https://doi.org/10.1182/blood.V120.21.4351.4351

Published: 2012

Journal Articles

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Marie Y. Detrait, MD, Helene Labussiere, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jihane Fattoum, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2011) 118 (21): 3087.

https://doi.org/10.1182/blood.V118.21.3087.3087

Published: 2011

Journal Articles

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Sandra Grass, MD, Klaus-Dieter Preuss, Aleksandra Wikowicz, Natalie Fadle, Evi Regitz, Gerhard Held, Leon Bernal-Mizrachi, MD, Sybille Raudies, Holger Thiele, Michael Pfreundschuh, MD, Frank Neumann

Blood (2011) 118 (21): 472.

https://doi.org/10.1182/blood.V118.21.472.472

Published: 2011

Journal Articles

Post-Transplant Immune Suppressive Therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem Cell Transplantation Using Low Dose Alemtuzumab In Vivo T Cell Depletion Combined with Alemtuzumab-Mediated In Vitro T Cell Depletion of the Graft

P.A. Von Dem Borne, MD, PhD, C.J.M. Halkes, MD, PhD, C.W.J. Starrenburg, W.A.F. Marijt, MD, PhD, J.H.F. Falkenburg, MD, PhD

Blood (2010) 116 (21): 2328.

https://doi.org/10.1182/blood.V116.21.2328.2328

Published: 2010

Journal Articles

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

Marieke Griffioen, M. Willy Honders, Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Elisabeth G.A. Lurvink, Roel Willemze, J.H. Frederik Falkenburg

Blood (2009) 114 (22): 4084.

https://doi.org/10.1182/blood.V114.22.4084.4084

Published: 2009

Journal Articles

Human Alloreactive CD4+ T Cells as Potent Effector Cells and Sole Mediators of Anti-Tumor Responses in a NOD/SCID Mouse Model for Human Acute Leukemia.

Sanja Stevanovic, Marieke Griffioen, PhD, Marianke LJ Van Schie, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Bart Nijmeijer, PhD

Blood (2008) 112 (11): 1245.

https://doi.org/10.1182/blood.V112.11.1245.1245

Published: 2008

Journal Articles

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Ann E Woolfrey, MD, John Klein, PhD, Michael D Haagenson, MS, Stephen R Spellman, MS, Minoo Battiwalla, MD, James L. Gajewski, MD, Gregory A. Hale, MD, John Horan, MD, MPH, Carolyn K Hurley, PhD, Craig Kollman, PhD, Susana Marino, MD, PhD, Machteld Oudshoorn, PhD, Effie W Petersdorf, MD, Olle Ringdén, MD, PhD, Michelle Setterholm, Stephanie J. Lee, MD, MPH

Blood (2008) 112 (11): 563.

https://doi.org/10.1182/blood.V112.11.563.563

Published: 2008

Journal Articles

Phenotypic and Functional Effects of Novel Akt Inhibitor Perifosine on Immune System.

Weihua Song, MD, Teru Hideshima, MD, PhD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2008) 112 (11): 1555.

https://doi.org/10.1182/blood.V112.11.1555.1555

Published: 2008

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Marieke Griffioen, Edith D. van der Meijden, M. Willy Honders, Caroline Rutten, Simone A.P. van Luxemburg-Heijs, Peter A. von dem Borne, Roelof Willemze, J.H. Frederik Falkenburg

Blood (2007) 110 (11): 1800.

https://doi.org/10.1182/blood.V110.11.1800.1800

Published: 2007

Journal Articles

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Lisa M. Rimsza, MD, Michael L. LeBlanc, PhD, Robin A. Roberts, BS, Joseph M. Unger, MS, Thomas P. Miller, MD, Constantine M. Sabalos, MS, Ralph R. Martel, PhD, Elias Campo, MD, Andreas Rosenwald, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Natalie Johnson, MD, Randy D. Gascoyne, MD

Blood (2007) 110 (11): 50.

https://doi.org/10.1182/blood.V110.11.50.50

Published: 2007

Journal Articles

Proteomic Profile of Human Gut Biopsies from Celiac Patients with and without Severe Complications.

Michele Spina, MD, Vallì De Re, MD, Maria Paola Simula, Laura Caggiari, Nicoletta Orzes, MD, Alessandro Da Ponte, MD, Leandro Apollonia, MD, Riccardo Dolcetti, MD, Alfonso Colombatti, MD, Vincenzo Canzonieri, MD, Renato Cannizzaro, MD

Blood (2006) 108 (11): 3899.

https://doi.org/10.1182/blood.V108.11.3899.3899

Published: 2006

Journal Articles

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Stephanie J. Lee, MD, MPH, John Klein, PhD, Michael Haagenson, MS, Lee Ann Baxter-Lowe, PhD, Dennis Confer, MD, Mary Eapen, MBBS, Marcelo Fernandez-Vina, PhD, Neal Flomenberg, MD, Mary Horowitz, MD, Carolyn Hurley, PhD, Harriet Noreen, CHS, Machteld Oudshoorn, PhD, Effie Petersdorf, MD, Michelle Setterholm, MS, Stephen Spellman, MS, Daniel Weisdorf, MD, Thomas M. Williams, MD, Claudio Anasetti, MD

Blood (2006) 108 (11): 172.

https://doi.org/10.1182/blood.V108.11.172.172

Published: 2006

Journal Articles

Detection of HTLV1 in Patients with B and T-Cell Malignancies Which Are Different to Adult T-Cell Leukemia-Lymphoma: A Prospective Study.

Jose J.M. Marquez, MD, Natalia N.O. Ortiz, PhD, Ramon R.C. Cisterna, MD, Jose Maria J.B. Beltran de Heredia, MD

Blood (2006) 108 (11): 3869.

https://doi.org/10.1182/blood.V108.11.3869.3869

Published: 2006

Journal Articles

DNA from Potentally Oncogenic Viruses Is Not Detected in Guthrie Cards from Chlidren Who Later Developed Acute Lymphoblastic Leukaemia.

Britt Gustafsson, MD, Gordana Bogdanovic, MD, PhD, Asa Gustafsson Jernberg, MD, PhD, Kristina Broliden, MD, Peter Priftakis, MD, PhD

Blood (2005) 106 (11): 4540.

https://doi.org/10.1182/blood.V106.11.4540.4540

Published: 2005

Journal Articles

Impact of Molecular HLA Matching for Allogeneic Stem Cell Transplantation from Unrelated Donors.

Yves Chalandon, MD, Joerg Halter, MD, Tayfun Guengoer, MD, Andre Tichelli, MD, Grazia Nicoloso de Faveri, MD, Bernard Chapuis, MD, Reinhard Seger, MD, Urs Schanz, MD, Alois Gratwohl, MD, Eddy Roosnek, PhD, Jean-Marie Tiercy, PhD, Jakob R. Passweg, MD

Blood (2004) 104 (11): 979.

https://doi.org/10.1182/blood.V104.11.979.979

Published: 2004

Journal Articles

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Neal Flomenberg, Lee Ann Baxter-Lowe, Dennis Confer, Marcelo Fernandez-Vina, Alexandra Filipovich, Mary Horowitz, Carolyn Hurley, Craig Kollman, Claudio Anasetti, Harriet Noreen, Ann Begovich, William Hildebrand, Effie Petersdorf, Barbara Schmeckpeper, Michelle Setterholm, Elizabeth Trachtenberg, Thomas Williams, Edmond Yunis, Daniel Weisdorf

Blood (2004) 104 (7): 1923–1930.

https://doi.org/10.1182/blood-2004-03-0803

Published: 2004

NARROW

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

Class II HLA Epitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

Post-Transplantation High Dose Cyclophosphamide As Gvhd Prophylaxis in 9/10 HLA-Matched Unrelated Donors Hematopoietic Stem Cell Transplantation

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Post-Transplant Immune Suppressive Therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem Cell Transplantation Using Low Dose Alemtuzumab In Vivo T Cell Depletion Combined with Alemtuzumab-Mediated In Vitro T Cell Depletion of the Graft

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

Human Alloreactive CD4+ T Cells as Potent Effector Cells and Sole Mediators of Anti-Tumor Responses in a NOD/SCID Mouse Model for Human Acute Leukemia.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Phenotypic and Functional Effects of Novel Akt Inhibitor Perifosine on Immune System.

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Proteomic Profile of Human Gut Biopsies from Celiac Patients with and without Severe Complications.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Detection of HTLV1 in Patients with B and T-Cell Malignancies Which Are Different to Adult T-Cell Leukemia-Lymphoma: A Prospective Study.

DNA from Potentally Oncogenic Viruses Is Not Detected in Guthrie Cards from Chlidren Who Later Developed Acute Lymphoblastic Leukaemia.

Impact of Molecular HLA Matching for Allogeneic Stem Cell Transplantation from Unrelated Donors.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only